Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Trojsi

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Biomedicines|March 29, 2023
The <i>HFE</i> p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with <i>SOD1</i> MutationsAntonio Canosa, Andrea Calvo, Gabriele Mora, et al.
Neurobiology of Aging|January 7, 2016
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansionAdriano Chiò, Gabriele Mora, Mario Sabatelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2020
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3Lorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Muscle & Nerve|August 3, 2024
Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersenAlessandra Govoni, Giulia Ricci, Silvia Bonanno, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2022
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on diseaseLorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Journal of Neurology|April 3, 2024
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosisElisabetta Maida, Marcello Moccia, Raffaele Palladino, et al.
European Journal of Neurology|September 23, 2022
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trialEttore Beghi, Elisabetta Pupillo, Elisa Bianchi, et al.
Journal of Neuromuscular Diseases|November 14, 2022
Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European SurveyLynda El-Hassar, Ahmed Amara, Benoit Sanson, et al.
Cell Genomics|October 22, 2024
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic dataSara Saez-Atienzar, Cleide Dos Santos Souza, Ruth Chia, et al.
Neuron|March 24, 2018
Genome-wide Analyses Identify KIF5A as a Novel ALS GeneAude Nicolas, Kevin P Kenna, Alan E Renton, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Biomedicines|March 29, 2023
The <i>HFE</i> p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with <i>SOD1</i> MutationsAntonio Canosa, Andrea Calvo, Gabriele Mora, et al.
Neurobiology of Aging|January 7, 2016
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansionAdriano Chiò, Gabriele Mora, Mario Sabatelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2020
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3Lorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Muscle & Nerve|August 3, 2024
Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersenAlessandra Govoni, Giulia Ricci, Silvia Bonanno, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2022
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on diseaseLorenzo Maggi, Luca Bello, Silvia Bonanno, et al.
Journal of Neurology|April 3, 2024
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosisElisabetta Maida, Marcello Moccia, Raffaele Palladino, et al.
European Journal of Neurology|September 23, 2022
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trialEttore Beghi, Elisabetta Pupillo, Elisa Bianchi, et al.
Journal of Neuromuscular Diseases|November 14, 2022
Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European SurveyLynda El-Hassar, Ahmed Amara, Benoit Sanson, et al.
Cell Genomics|October 22, 2024
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic dataSara Saez-Atienzar, Cleide Dos Santos Souza, Ruth Chia, et al.
Neuron|March 24, 2018
Genome-wide Analyses Identify KIF5A as a Novel ALS GeneAude Nicolas, Kevin P Kenna, Alan E Renton, et al.
Pageof 14